Related references
Note: Only part of the references are listed.USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair
Jennifer J. McCann et al.
CANCER RESEARCH (2020)
Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma
Xue Wen et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation
Sunbin Ling et al.
GUT (2020)
Modulating intracellular oxidative stress via engineered nanotherapeutics
Jinming Hu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
CRISPR screen in regulatory T cells reveals modulators of Foxp3
Jessica T. Cortez et al.
NATURE (2020)
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
Yu Wang et al.
CELL COMMUNICATION AND SIGNALING (2020)
Cascade of reactive oxygen species generation by polyprodrug for combinational photodynamic therapy
Zujian Feng et al.
BIOMATERIALS (2020)
Is the era of sorafenib over? A review of the literature
Guanghan Fan et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cancer Chemotherapy: Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance (Adv. Sci. 7/2019)
Jia Liu et al.
Advanced Science (2019)
Tailored Design of an ROS-Responsive Drug Release Platform for Enhanced Tumor Therapy via Sequential Induced Activation Processes
Tingting Luan et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Hepatocellular carcinoma: Current situation and challenge
Zhao Li et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2019)
The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells
Li Wang et al.
ONCOTARGETS AND THERAPY (2019)
USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity
Xing Huang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells
Juliane Liese et al.
ANTI-CANCER DRUGS (2019)
USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer
Robyn Laura Kosinsky et al.
CELL DEATH & DISEASE (2019)
Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma
Jingxiong Lu et al.
SMALL (2018)
An Integrated Therapeutic Delivery System for Enhanced Treatment of Hepatocellular Carcinoma
Zhou Ye et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells
Franziska Paech et al.
TOXICOLOGY (2018)
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
Kevin Van der Jeught et al.
ACS NANO (2018)
A novel galactose-PEG-conjugated biodegradable copolymer is an efficient gene delivery vector for immunotherapy of hepatocellular carcinoma
Ling Liu et al.
BIOMATERIALS (2018)
Reactive Oxygen Species (ROS)-Responsive Charge-Switchable Nanocarriers for Gene Therapy of Metastatic Cancer
Jiajia Xiang et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
Sunbin Ling et al.
MOLECULAR ONCOLOGY (2017)
Graphene Quantum Dots Downregulate Multiple Multidrug-Resistant Genes via Interacting with Their C-Rich Promoters
Chao Luo et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery
Xin Liu et al.
ADVANCED MATERIALS (2016)
Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma
Hong Yao et al.
CANCER LETTERS (2016)
Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy
Junjie Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Ubiquitin-specific peptidase 22 functions and its involvement in disease
Johanna Melo-Cardenas et al.
ONCOTARGET (2016)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study
Wei Bai et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice
Mingrong Cheng et al.
CANCER BIOLOGY & THERAPY (2012)
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
Sylvia Julien et al.
CLINICAL CANCER RESEARCH (2012)
Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
Romain Coriat et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning
Lara Milane et al.
CANCER CELL INTERNATIONAL (2011)
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells
Luigi Fiume et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
